ME logo 23andMe Holding Co - Class A : ME

ME

Stock Data

$0.61

Change up

$0.00 (0.00%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

DIAGNOSTICS & RESEARCH

23andMe Holding Co. is a pioneer in consumer genetics testing, offering insights into genetic ancestry, health risks, and how DNA affects medication responses. Beyond personal genetics, it operates Lemonaid telehealth for easy access to medical consultations. In the realm of drug development, 23andMe is actively working on novel therapies in areas like oncology and cardiovascular diseases, aiming to transform patient care. Its innovative approach includes developing drugs that leverage genetic insights, such as a monoclonal antibody in clinical trials for cancer treatment.

All ME Articles

11 Articles

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.